Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology

• María José Ferri,

  Affiliations Clinic Laboratory, Dr. Josep Trueta University Hospital, Girona, Spain, Department of Biology, University of Girona, Girona, Spain

  ⨯
• Marc Saez,

  Affiliations Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain, CIBER of Epidemiology and Public Health (CIBERESP), Girona, Spain

  ⨯
• Joan Figueras,

  Affiliation Hepato-biliary and Pancreatic Surgery Unit, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain

  ⨯
• Esther Fort,

  Affiliation Gastroenterology Unit, Dr. Josep Trueta University Hospital, Girona, Spain

  ⨯
• Miriam Sabat,

  Affiliation Gastroenterology Unit, Hospital Santa Caterina, Salt, Girona, Spain

  ⨯
• Santiago López-Ben,

  Affiliation Hepato-biliary and Pancreatic Surgery Unit, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain

  ⨯
• Rafael de Llorens,

  Affiliation Department of Biology, University of Girona, Girona, Spain

  ⨯
• Rosa Núria Aleixandre,

  Affiliation Clinic Laboratory, Dr. Josep Trueta University Hospital, Girona, Spain

  ⨯
• Rosa Peracaula

  * E-mail: rosa.peracaula@udg.edu

  Affiliation Department of Biology, University of Girona, Girona, Spain

  ⨯